Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Landis+Gyr (LANDI.S)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (CHF)	Price Target (CHF)	Rating
2021-12-31	NaN	63.00	Neutral
2023-03-23	67.55	67.00	Neutral
2023-07-26	75.10	-	No Rating
2023-07-27	76.15	67.00	Neutral
2023-09-01	66.15	-	No Rating
2023-09-06	64.90	67.00	Neutral
2024-05-03	72.50	71.00	Neutral
2024-05-10	72.60	72.00	Neutral

Disclosures

UBS AG is acting as financial advisor to Landis+Gyr on the review of strategic options for its EMEA business.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.
UBS Fund Management (Switzerland) AG beneficially owns more than 5% of the total issued share capital of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.